Preview Mode Links will not work in preview mode

Mar 20, 2024

Featuring perspectives from Dr Melissa Johnson, including the following topics:
  • Role of biomarker testing in optimal selection of first-line therapy for patients with non-small cell lung cancer (NSCLC) (0:00)
  • Efficacy and safety with datopotamab deruxtecan for previously treated NSCLC (15:45)
  • Antitumor activity with...


Dec 11, 2023

Featuring perspectives from Dr Luis Paz-Ares, Dr Zofia Piotrowska and Dr David R Spigel, including the following topics:

  • Introduction (0:00)
  • Localized Non-Small Cell Lung Cancer (NSCLC) (9:29)
  • EGFR-Mutated Metastatic NSCLC (34:12)
  • Other Targeted Treatment for Metastatic NSCLC (55:04)
  • Updates on Immunotherapy in...


Dec 11, 2023

Implications of Recent Data Sets for the Current and Future Management of Lung Cancer | Faculty Presentation 3: Immunotherapeutic and Other Novel Strategies for Metastatic NSCLC and Small Cell Lung Cancer — Aaron Lisberg, MD  

CME information and select...


Dec 11, 2023

Implications of Recent Data Sets for the Current and Future Management of Lung Cancer | Faculty Presentation 1: Incorporation of Targeted and Immunotherapeutic Strategies into the Management of Nonmetastatic Non-Small Cell Lung Cancer (NSCLC) — Luis Paz-Ares, MD, PhD

CME information and select...


Dec 11, 2023

Implications of Recent Data Sets for the Current and Future Management of Lung Cancer | Faculty Presentation 2: Targeted Therapy for Metastatic NSCLC — Zofia Piotrowska, MD, MHS 

CME information and select publications